Enzyre
PrivateLast Round
Series A
Nov 2, 2022
Total Funding Raised
$15.74M
Company Overview
Enzyre operates in Healthcare & Life Sciences and is based in Nijmegen. Its latest recorded funding round was a Series A round in November 2022.
Enzyre is a medical device company that develops point-of-care diagnostic technology for blood coagulation analysis to facilitate personalized medicine for patients with bleeding disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Precision Medicine, Biotechnology, Healthcare Analytics, Telemedicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enzyre Comparables
Compare Enzyre with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Coagulo Medical Technologies | 80% | |
| Universal Biosensors Inc | 77% | |
| Perosphere Technologies Inc. | 77% |
For institutional investors. Book with your work email.
Enzyre Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 2, 2022 | ||||
| Debt | Jul 27, 2020 | ||||
| Grant | Apr 30, 2019 | ||||
| Seed | Apr 30, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Enzyre Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Takeda Ventures | Series A |
| Oost NL | Debt, Series A |
| Novalis Biotech | Debt, Series A |
| East Netherlands Development Agency (Oost NL) | Debt, Series A |
| i&i Prague | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2025
Showcasing EnzySystem at Venture Summit West on April 2-3, 2025.
- Mar 20, 2025
Selected as one of 150 Top Innovators for Venture Summit West.
For institutional investors. Book with your work email.
Enzyre Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Enzyre's valuation, stock price, and market status.
Is Enzyre a public or private company?
Enzyre is a private company.
What is the current stock price of Enzyre?
Enzyre is a private company, so its shares have no public market price. Caplight tracks Enzyre's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enzyre worth (valuation)?
Valuation information for Enzyre is not publicly available.
Can I buy Enzyre stock?
Enzyre shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enzyre's last funding round?
Enzyre's most recent funding round was Series A on November 2, 2022.
Who are the main investors in Enzyre?
Key investors in Enzyre include Oost NL, East Netherlands Development Agency (Oost NL).
Will Enzyre IPO soon?
No public IPO plans have been announced for Enzyre.
How can I track Enzyre secondary market activity?
Caplight tracks bids, offers, and trades in Enzyre's shares on secondary markets.